3 results
Not approvedWill not start
To better understand the utilities of the new BETACONNECT device and characterize its contribution to adherence, we plan to prospectively follow-up MS patients using the device for 24 weeks.
Approved WMOCompleted
Primary Objective:Evaluating the predictive value of CAUS to assess the steatosis severity, combining multiple CAUS parameters (RAC, LAT, SNR, MU, AX), with 1H-MRS as a reference in adult patients with CIF.Secondary Objective(s):-To assess the…
Approved WMOWill not start
Our aim is to assess the sequential response of different endothelial markers following DDAVP administration. This information will be used to expand the population PK model and may enhance our insight in the mechanisms underlying the DDAVP response…